bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

 
  Other news for:
Abnormalities
Influenza
Pregnancy
Pregnancy Complications
Viruses
 Resources from HONselect
Antiviral Flu Drugs Safe in Mid-to-Late Pregnancy: Study
No higher rates of complications seen in babies when mom took these meds after 22 weeks of pregnancy

By Robert Preidt

WEDNESDAY, March 1, 2017 (HealthDay News) -- Taking antiviral drugs to prevent or treat flu during pregnancy doesn't appear to put the health of the fetus at risk, a new study finds.

Researchers reviewed information from nearly 6,000 pregnant women who were given a prescription for antiviral drugs to treat flu. The prescriptions were for either oseltamivir (Tamiflu) or zanamivir (Relenza). The study didn't include women who took the drugs before 22 weeks of pregnancy.

The researchers compared these women to nearly 700,000 expectant mothers who didn't take the drugs during pregnancy.

Babies born to mothers prescribed the antiviral drugs didn't have higher rates of complications. The researchers looked at problems such as low birth weight, preterm birth, stillbirth and birth defects.

The findings support previous studies showing that these drugs don't put babies at risk, according to study author Dr. Sofie Graner from the Karolinska Institute in Stockholm, Sweden, and colleagues.

U.S. and European health officials recommend these drugs for pregnant women with confirmed or suspected flu. The drugs are also recommended for pregnant women who've had close contact with people who have the flu. But there's been limited knowledge about the safety of these drugs when used during pregnancy, the researchers noted.

The study was published Feb. 28 in the journal BMJ.

More information

The U.S. Centers for Disease Control and Prevention has more on antiviral flu drugs.

SOURCE: BMJ, news release, Feb. 28, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=720120

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Specialty Chemicals and Products
Women
Research Personnel
Mothers
Risk
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact